Bordet Scientific Publications

Iron-deficiency anemia evaluation and treatment in hospitalized cancer patients: a feasibility study.

Meyers M, Paesmans M, Fleur W, Libert I, Klášterský J

Iron-deficiency anemia evaluation and treatment in hospitalized cancer patients: a feasibility study.

Meyers M, Paesmans M, Fleur W, Libert I, Klášterský J

Iron-deficiency anemia evaluation and treatment in hospitalized cancer patients: a feasibility study.

Adolescent Engagement With a Multicomponent mHealth Tool: Identifying Usage Patterns, Determinants, and Health Behavior Change in an Intervention Trial.

Peuters C, DeSmet A, Maenhout L, Cardon G, Debeer D, Crombez G

Adolescent Engagement With a Multicomponent mHealth Tool: Identifying Usage Patterns, Determinants, and Health Behavior Change in an Intervention Trial.

Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectives.

Matos L, van Ramshorst M, Müller V, Agostinetto E, Linn S, Lambertini M, Dieras V, le Du F, Braga S, Criscitiello C, Jerzak KJ, Morgan G, Brucker S, von Kroge P, Haidinger R, Rodríguez Recio G, Schumacher-Wulf E, Fontes Sousa M, Schettini F, Laakmann E

Brain imaging screening in metastatic breast cancer: patients' and physicians' perspectives.

Gallbladder Volvulus: A Rare Entity with \"Beak Sign\" and \"Whirl Sign\".

Vlasselaer M, Pezzullo M, Liberale G

Gallbladder Volvulus: A Rare Entity with \"Beak Sign\" and \"Whirl Sign\".

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE.

Matikas A, Naume B, Wildiers H, Sonke G, Dieci MV, Karakatsanis A, Andersson A, Barnekow E, Kessler LE, Einbeigi Z, Killander F, Linderholm B, Schiza A, Valachis A, Nearchou A, Engebraaten O, Porojnicu A, Soland MH, Mannsåker B, Raj SX, Blix ES, Nordstrand CS, Lambertini M, Vernieri C, Punie K, Sotiriou C, Bergh J, Villacampa G, Zouzos A, Hellström M, Hartman J, Foukakis T

Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE.

Managing relapses during or after adjuvant CDK4/6 inhibitors in HR-positive/HER2-negative early breast cancer: an emerging challenge.

Gerosa R, Gentile G, Arecco L, Dauccia C, Nannini S, Lobo-Martins S, Agostinetto E, Lambertini M, Santoro A, Aftimos P, Piccart-Gebhart M, de Azambuja E

Managing relapses during or after adjuvant CDK4/6 inhibitors in HR-positive/HER2-negative early breast cancer: an emerging challenge.

Gerosa R, Gentile G, Arecco L, Dauccia C, Nannini S, Lobo-Martins S, Agostinetto E, Lambertini M, Santoro A, Aftimos P, Piccart-Gebhart M, de Azambuja E

Managing relapses during or after adjuvant CDK4/6 inhibitors in HR-positive/HER2-negative early breast cancer: an emerging challenge.

Gerosa R, Gentile G, Arecco L, Dauccia C, Nannini S, Lobo-Martins S, Agostinetto E, Lambertini M, Santoro A, Aftimos P, Piccart-Gebhart M, de Azambuja E

Managing relapses during or after adjuvant CDK4/6 inhibitors in HR-positive/HER2-negative early breast cancer: an emerging challenge.

Erasmus Hospital

View all of Erasmus's scientific publications

Erasmus's academic publications

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital

Scientific publications from the Queen Fabiola Children's Hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Scientific publications by Jules Bordet

Bordet Scientific Publications